Brief: Moberg Pharma Q4 EBIT Loss of SEK 4.6 Million

Moberg Pharma AB (publ)

07/02/2023 07:05

Feb 7 (Reuters) - Moberg Pharma Q4 EPS SEK -0.03.
* Q4 net income SEK -3.1 million
* Q4 EBITDA SEK -3.9 million